OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
4
Results
Show all
Save search
Copy query
Show results for
Unknown
(4)
Publication Date
Release Date
2021
(2)
2023
(1)
2015
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Senataxin controls meiotic silencing through ATR activation and chromatin remodeling.
Not available
S-EPMC4860845
|
biostudies-literature
Cite
External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry.
Not available
S-EPMC8216357
|
biostudies-literature
Cite
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy.
Not available
S-EPMC9989382
|
biostudies-literature
Cite
Antibiotic Resistance Prevalence and Trends in Patients Infected with
Helicobacter pylori
in the Period 2013-2020: Results of the European Registry on
H. pylori
Management (Hp-EuReg).
Not available
S-EPMC8471667
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets